These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 46681)

  • 1. Interaction of contraceptive progestins and related compounds with the oestrogen receptor. Part II: Effect on (3H)oestradiol binding to the rat uterine receptor in vitro.
    van Kordelaar JM; Vermorken AJ; de Weerd CJ; van Rossum JM
    Acta Endocrinol (Copenh); 1975 Jan; 78(1):165-79. PubMed ID: 46681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of contraceptive progestins and related compounds with the oestrogen receptor. Part I: Effect on (3H)oestradiol distribution pattern in the ovariectomized rat.
    van Kordelaar JB; Broekman MM; van Rossum JM
    Acta Endocrinol (Copenh); 1975 Jan; 78(1):145-64. PubMed ID: 46680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinities of progestogen and estrogen receptors in rabbit uterus for synthetic progestogens.
    Terenius L
    Steroids; 1974 Jun; 23(6):90919. PubMed ID: 4134774
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol.
    Kharma K; Stone S; Thorneycroft IH; Nakamura RM; Mishell DR
    Am J Obstet Gynecol; 1972 Mar; 112(5):676-80. PubMed ID: 4110418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLASSIFICATION OF ORAL CONTRACEPTIVES.
    SMIBERT J
    Med J Aust; 1965 Jan; 1(5):162. PubMed ID: 14247941
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthetic progestins: in vitro potency on human endometrium and specific binding to cytosol receptor.
    Shapiro SS; Dyer RD; Colás AE
    Am J Obstet Gynecol; 1978 Nov; 132(5):549-54. PubMed ID: 717455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the binding of oestradiol to uterine oestrogen receptors induced by some progesterone and 19-nor-testosterone derivatives.
    Di Carlo F; Gallo E; Conti G; Racca S
    J Endocrinol; 1983 Sep; 98(3):385-9. PubMed ID: 6194237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative metabolism of 17alpha-ethynyl steroids used in oral contraceptives.
    Ranney RE
    J Toxicol Environ Health; 1977 Sep; 3(1-2):139-66. PubMed ID: 411940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of progestins with steroid receptors in human uterus.
    Kasid A; Buckshee K; Hingorani V; Laumas KR
    Biochem J; 1978 Nov; 176(2):531-9. PubMed ID: 743257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Competition between estradiol and various progestogens at the level of the rat hypothalamus].
    Rosner JM; Declercq de Pérez Bedés G; Gomez E
    Ann Endocrinol (Paris); 1974; 35(2):173-6. PubMed ID: 4371464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FUNDAMENTALS IN THE USE OF PROGESTINS FOR THE CONTROL OF CONCEPTION.
    GOLDZIEHER JG
    Appl Ther; 1964 Jun; 6():503-7. PubMed ID: 14167337
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroid hormones and the fertilizing capacity of spermatozoa.
    Briggs MH
    Steroids; 1973 Oct; 22(4):547-53. PubMed ID: 4127001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of functional groups of 19-nor-progestogens to binding to progesterone and estradiol-17beta receptors in rabbit uterus.
    Tamaya T; Nioka S; Furuta N; Shimura T; Takano N
    Endocrinology; 1977 Jun; 100(6):1579-84. PubMed ID: 858280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5alpha-reduction of norethisterone enhances its binding affinity for androgen receptors but diminishes its androgenic potency.
    Lemus AE; Enríquez J; García GA; Grillasca I; Pérez-Palacios G
    J Steroid Biochem Mol Biol; 1997 Jan; 60(1-2):121-9. PubMed ID: 9182866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [What happens in our patients' bodies to the steroid hormones we prescribe? 2. Synthetic progestins].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1981 Dec; 9(12):827-30. PubMed ID: 12337684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemistry, pharmacology and clinical pharmacology of oral contraceptives.
    Fekete G
    Ther Hung (Ger Ed); 1968; 16():1-8. PubMed ID: 12334483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The sialic acid content in mouse female reproductive organs as a quantitative parameter for testing the estrogenic and antiestrogenic effect, antiestrogenic depot effect, and dissociated effect of estrogens on the uterus and vagina.
    Nishino Y; Neumann F
    Acta Endocrinol Suppl (Copenh); 1974; 187():3-62. PubMed ID: 4134905
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
    Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
    Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of progestogenic substances on the uterine secretion of spayed rats primed with oestradiol.
    Meglioli G; Kalvoda J; Desaulles PA
    Horm Res; 1973; 4(2):97-106. PubMed ID: 4127110
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.